Results for tag: "Syndromic Multiplex Panels"

The Syndromic Multiplex Panels market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. It is composed of tests that use multiplexing technology to detect multiple pathogens from a single sample. This technology enables the simultaneous detection of multiple pathogens in a single test, reducing the time and cost associated with traditional testing methods. It also allows for the detection of multiple pathogens in a single sample, which can be beneficial in the diagnosis of complex diseases. The Syndromic Multiplex Panels market is driven by the increasing demand for rapid and accurate diagnosis of infectious diseases. Additionally, the growing prevalence of infectious diseases, the increasing availability of multiplexing technology, and the rising demand for point-of-care testing are expected to drive the market growth. Some of the major companies in the Syndromic Multiplex Panels market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, Hologic, Luminex Corporation, Qiagen, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more